DGX

205.04

4.45% 8.73

Dopo l'orario di chiusura: 209.28 4.24 +2.07%

Quest Diagnostics Inc (DGX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$196.31

Aprire:

$203.25

Volume 24 ore:

2.43M

Relative Volume:

2.41

Capitalizzazione di mercato:

$22.69B

Reddito:

$11.04B

Utile/perdita netta:

$1.04B

Rapporto P/E:

23.40

EPS:

8.7626

Flusso di cassa netto:

$1.36B

1 W Prestazione:

+5.60%

1M Prestazione:

+5.01%

6M Prestazione:

+11.05%

1 anno Prestazione:

+26.68%

Intervallo 1D:

$202.13

$209.79

Intervallo di 1 settimana:

$190.23

$209.79

Portata 52W:

$164.65

$213.50

Quest Diagnostics Inc Stock (DGX) Company Profile

Nome

Quest Diagnostics Inc

Settore

Healthcare (1113)

Industria

Diagnostics & Research (52)

Telefono

(973) 520-2700

Indirizzo

500 PLAZA DRIVE, SECAUCUS

Dipendente

57,000

Cinguettio

@QuestDX

Prossima data di guadagno

2026-04-21

Ultimi documenti SEC

DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DGX Quest Diagnostics Inc	205.04	21.73B	11.04B	1.04B	1.36B	8.7626
TMO Thermo Fisher Scientific Inc	524.57	195.48B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	194.54	138.36B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	569.01	46.31B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	122.09	34.18B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	335.23	32.95B	3.17B	642.63M	516.49M	10.77

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-30	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-25	Downgrade	Robert W. Baird	Outperform → Neutral
2025-04-02	Iniziato	Redburn Atlantic	Buy
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-01-06	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-12-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Ripresa	Jefferies	Buy
2024-10-23	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-08-28	Ripresa	Evercore ISI	In-line
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-02-26	Iniziato	Leerink Partners	Market Perform
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Iniziato	Barclays	Equal Weight
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-06-29	Iniziato	Piper Sandler	Neutral
2023-05-02	Downgrade	BofA Securities	Buy → Neutral
2023-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-01-23	Iniziato	Evercore ISI	In-line
2022-11-17	Downgrade	Citigroup	Neutral → Sell
2022-08-22	Ripresa	Morgan Stanley	Equal-Weight
2022-04-04	Downgrade	Citigroup	Buy → Neutral
2022-02-23	Downgrade	UBS	Buy → Neutral
2022-02-02	Downgrade	Jefferies	Buy → Hold
2022-01-28	Downgrade	Deutsche Bank	Buy → Hold
2021-05-04	Aggiornamento	UBS	Neutral → Buy
2021-03-12	Downgrade	Robert W. Baird	Outperform → Neutral
2020-10-21	Aggiornamento	Argus	Hold → Buy
2020-07-29	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-09	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-06-02	Aggiornamento	Deutsche Bank	Hold → Buy
2020-04-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Aggiornamento	Citigroup	Neutral → Buy
2020-04-27	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2020-03-27	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Downgrade	Barclays	Overweight → Equal Weight
2019-12-19	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-07-15	Downgrade	Goldman	Neutral → Sell
2019-04-02	Aggiornamento	Jefferies	Hold → Buy
2019-03-18	Ripresa	Credit Suisse	Neutral
2019-01-31	Downgrade	Argus	Buy → Hold
2019-01-17	Iniziato	UBS	Neutral
2019-01-03	Downgrade	BofA/Merrill	Neutral → Underperform
2018-12-03	Downgrade	BofA/Merrill	Buy → Neutral
2018-11-30	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

06:12 AM

Is Quest Diagnostics Inc (DGX) Overvalued After 4.5% Rally? GF V - GuruFocus

06:12 AM

01:00 AM

Why Is Quest Diagnostics Stock Soaring Tuesday?Quest Diagnostics (NYSE:DGX) - Benzinga

01:00 AM

12:51 PM

Quest Diagnostics raises guidance following earnings beat - marketscreener.com

12:51 PM

12:46 PM

Quest Diagnostics Incorporated Q1 2026 Earnings Call Summary - Yahoo Finance

12:46 PM

12:05 PM

Quest Diagnostics raises 2026 forecast, CEO highlights broad-based growth - marketscreener.com

12:05 PM

10:45 AM

Quest Diagnostics Q1 Earnings Call Highlights - Yahoo Finance

10:45 AM

10:06 AM

Valmont Industries Posts Upbeat Q1 Results, Joins UnitedHealth Group, Quest Diagnostics And Other Big Sto - Benzinga

10:06 AM

09:33 AM

Quest Diagnostics Q1 2026 Earnings Call: Complete TranscriptQuest Diagnostics (NYSE:DGX) - Benzinga

09:33 AM

09:31 AM

Quest Diagnostics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

09:31 AM

08:52 AM

Quest Diagnostics' Q1 Earnings & Revenues Top Estimates, Stock Up - Yahoo Finance

08:52 AM

08:20 AM

Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

08:20 AM

07:55 AM

Quest Diagnostics (DGX) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

07:55 AM

07:42 AM

Quest Diagnostics raises full-year forecast, posts strong quarter on testing demand - marketscreener.com

07:42 AM

07:32 AM

Quest Diagnostics: Q1 Earnings Snapshot - marketscreener.com

07:32 AM

07:24 AM

Quest Diagnostics Inc (NYSE:DGX) Beats Q1 2026 Estimates and Raises Full-Year Guidance - ChartMill

07:24 AM

Quest Diagnostics Q1 Adjusted Earnings, Revenue Rise; Full-Year Outlook Upgraded -- Shares Up Pre-Bell - marketscreener.com

07:24 AM

07:20 AM

Quest Diagnostics stock up 3% on earnings beat, raised guidance By Investing.com - Investing.com Canada

07:20 AM

07:19 AM

Is Quest Diagnostics (DGX) Overvalued After Q1 2026 Earnings Bea - GuruFocus

07:19 AM

06:57 AM

(DGX) Quest Diagnostics Expects 2026 Adjusted EPS Range $10.63$10.83, vs. FactSet Est of $10.63 - marketscreener.com

06:57 AM

06:56 AM

Quest’s (NYSE:DGX) Q1 CY2026 Sales Beat Estimates - TradingView

06:56 AM

06:55 AM

Earnings Flash (DGX) Quest Diagnostics Incorporated Reports Q1 Revenue $2.90B, vs. FactSet Est of $2.83B - marketscreener.com

06:55 AM

Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q1 Adjusted EPS $2.50 per Share, vs. FactSet Est of $2.37 - marketscreener.com

06:55 AM

06:48 AM

Quest Diagnostics (NYSE: DGX) posts Q1 2026 growth and raises full-year outlook - Stock Titan

06:48 AM

06:47 AM

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 - PR Newswire

06:47 AM

Apr 20, 2026

Quest Diagnostics earnings on deck as margin expansion eyed By Investing.com - Investing.com Canada

Apr 20, 2026

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance

Apr 20, 2026

Quest Diagnostics (DGX) Sees Premarket Surge Amid Market Volatility - GuruFocus

Apr 20, 2026

Apr 18, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Apr 18, 2026

Apr 17, 2026

Quest Diagnostics Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2026

Apr 16, 2026

City of Hope to track 500 patients with blood test for earlier recurrence - Stock Titan

Apr 16, 2026

Apr 15, 2026

Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 15, 2026

Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings - Yahoo Finance

Apr 15, 2026

Quest Diagnostics Mirrors S&P 500 Index Sector Momentum Clearly - Kalkine Media

Apr 15, 2026

Apr 14, 2026

Baird Adjusts Price Target on Quest Diagnostics to $224 From $219, Maintains Neutral Rating - marketscreener.com

Apr 14, 2026

Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Apr 14, 2026

Patton Fund Management Inc. Has $5.56 Million Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat

Apr 14, 2026

Quest Diagnostics Incorporated $DGX Shares Sold by Atwater Malick LLC - MarketBeat

Apr 14, 2026

Quest Diagnostics (DGX) to Release Earnings on Tuesday - MarketBeat

Apr 14, 2026

Apr 10, 2026